Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study
托珠单抗可提高重症 COVID-19 住院患者的 28 天生存率:一项开放标签的前瞻性研究
期刊:Respiratory Research
影响因子:5
doi:10.1186/s12931-021-01914-6
Karampitsakos, Theodoros; Malakounidou, Elli; Papaioannou, Ourania; Dimakopoulou, Vasilina; Zarkadi, Eirini; Katsaras, Matthaios; Tsiri, Panagiota; Tsirikos, Georgios; Georgiopoulou, Vasiliki; Oikonomou, Ioanna; Davoulos, Christos; Velissaris, Dimitrios; Sampsonas, Fotios; Marangos, Markos; Akinosoglou, Karolina; Tzouvelekis, Argyris